Pharmidex will be attending National Cancer Research Institute (NCRI) conference
Oct 30, 2017

On November 5th-8th 2017 representatives of Pharmidex will be attending the National Cancer Research Institute (NCRI) Cancer Conference.

The UK’s largest forum showcasing the latest advances in cancer research. The Conference provides a platform for researchers, clinicians, people affected by cancer and industry representatives to come together to discuss, present and showcase high-quality research. Attended by 1500 delegates, this meeting represents an excellent opportunity to build collaborations and networks.


NCRI conference website.

Combinatorial Therapy: Targeting CD133+ Glioma Stem-like Cells with a Polysaccharide-Prodrug Complex Functionalised Gold Nanocages

24 Apr, 2024
Pharmidex , in collaboration with colleagues at the University of Brighton, is pleased to announce publication of our latest article

Luminex cytokines Analysis

13 Mar, 2024
Uncover valuable insights from a range of sources including plasma, bronchoalveolar lavage fluid, urine, and tissue supernatant with our comprehensive matrix evaluation services.

Pharmidex GLP/GCP Bioanalysis Offer

By Ash Alavijeh • 26 Feb, 2024
As an accredited GLP/GCP laboratory, Pharmidex provides comprehensive bioanalytical solutions tailored to meet your specific drug development needs.
More Posts
Share by: